Report Detail
Global Drug Device Combination Products Market Research Report 2019
- RnM3108021 |
- 12 March, 2019 |
- Global |
- 100 Pages |
- QYResearch |
- Other
Drug devices facilitate early diagnosis and reduced treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.
The global drug device combination product market size is expected to reach USD 176 billion by 2024. Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamlined, systematic, and collaborative system for the review of the aforementioned products. Safety guidelines and recommendations issued by these authorities are presumed to increase the adoption of these products in future and boost overall growth during the forecast period.
Severe side effects and drug interactions associated with therapeutics owing to drug absorption by unintended sites in the body are anticipated to induce need for targeted therapy, thereby propelling demand for drug-device combinations. For instance, consistent administration of Levodopa results in long-term complications such as motor fluctuations, dyskinesias, severe metabolic changes, and neurotoxic effects. These aforementioned factors drive the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products.
The global Drug Device Combination Products market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drug Device Combination Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug Device Combination Products market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbott Laboratories
Terumo Corporation
Stryker Corporation
Mylan N.V.
Medtronic
St.Jude Medical, Inc.
Allergan, Plc
Boston Scientific Corporation
Novartis AG
Teleflex Incorporated
C.R. Bard, Inc.
W.L.Core & Associates, Inc.
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Drug-eluting stents
Prefilled syringes
Wearable injectors
Insulin injector drug
Segment by Application
Hospitals and Clinics
Medical Laboratories
Others
Table of Contents
Executive Summary
1 Drug Device Combination Products Market Overview
- 1.1 Product Overview and Scope of Drug Device Combination Products
- 1.2 Drug Device Combination Products Segment by Type
- 1.2.1 Global Drug Device Combination Products Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Drug-eluting stents
- 1.2.3 Prefilled syringes
- 1.2.4 Wearable injectors
- 1.2.5 Insulin injector drug
- 1.3 Drug Device Combination Products Segment by Application
- 1.3.1 Drug Device Combination Products Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals and Clinics
- 1.3.3 Medical Laboratories
- 1.3.4 Others
- 1.4 Global Drug Device Combination Products Market by Region
- 1.4.1 Global Drug Device Combination Products Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Drug Device Combination Products Market Size
- 1.5.1 Global Drug Device Combination Products Revenue (2014-2025)
- 1.5.2 Global Drug Device Combination Products Production (2014-2025)
2 Global Drug Device Combination Products Market Competition by Manufacturers
- 2.1 Global Drug Device Combination Products Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Drug Device Combination Products Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Drug Device Combination Products Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Drug Device Combination Products Production Sites, Area Served, Product Types
- 2.5 Drug Device Combination Products Market Competitive Situation and Trends
- 2.5.1 Drug Device Combination Products Market Concentration Rate
- 2.5.2 Drug Device Combination Products Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Drug Device Combination Products Production Market Share by Regions
- 3.1 Global Drug Device Combination Products Production Market Share by Regions
- 3.2 Global Drug Device Combination Products Revenue Market Share by Regions (2014-2019)
- 3.3 Global Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Drug Device Combination Products Production
- 3.4.1 North America Drug Device Combination Products Production Growth Rate (2014-2019)
- 3.4.2 North America Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Drug Device Combination Products Production
- 3.5.1 Europe Drug Device Combination Products Production Growth Rate (2014-2019)
- 3.5.2 Europe Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Drug Device Combination Products Production (2014-2019)
- 3.6.1 China Drug Device Combination Products Production Growth Rate (2014-2019)
- 3.6.2 China Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Drug Device Combination Products Production (2014-2019)
- 3.7.1 Japan Drug Device Combination Products Production Growth Rate (2014-2019)
- 3.7.2 Japan Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Drug Device Combination Products Consumption by Regions
- 4.1 Global Drug Device Combination Products Consumption by Regions
- 4.2 North America Drug Device Combination Products Consumption (2014-2019)
- 4.3 Europe Drug Device Combination Products Consumption (2014-2019)
- 4.4 China Drug Device Combination Products Consumption (2014-2019)
- 4.5 Japan Drug Device Combination Products Consumption (2014-2019)
5 Global Drug Device Combination Products Production, Revenue, Price Trend by Type
- 5.1 Global Drug Device Combination Products Production Market Share by Type (2014-2019)
- 5.2 Global Drug Device Combination Products Revenue Market Share by Type (2014-2019)
- 5.3 Global Drug Device Combination Products Price by Type (2014-2019)
- 5.4 Global Drug Device Combination Products Production Growth by Type (2014-2019)
6 Global Drug Device Combination Products Market Analysis by Applications
- 6.1 Global Drug Device Combination Products Consumption Market Share by Application (2014-2019)
- 6.2 Global Drug Device Combination Products Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Drug Device Combination Products Business
- 7.1 Abbott Laboratories
- 7.1.1 Abbott Laboratories Drug Device Combination Products Production Sites and Area Served
- 7.1.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.1.3 Abbott Laboratories Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Terumo Corporation
- 7.2.1 Terumo Corporation Drug Device Combination Products Production Sites and Area Served
- 7.2.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.2.3 Terumo Corporation Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Stryker Corporation
- 7.3.1 Stryker Corporation Drug Device Combination Products Production Sites and Area Served
- 7.3.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.3.3 Stryker Corporation Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Mylan N.V.
- 7.4.1 Mylan N.V. Drug Device Combination Products Production Sites and Area Served
- 7.4.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.4.3 Mylan N.V. Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Medtronic
- 7.5.1 Medtronic Drug Device Combination Products Production Sites and Area Served
- 7.5.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.5.3 Medtronic Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 St.Jude Medical, Inc.
- 7.6.1 St.Jude Medical, Inc. Drug Device Combination Products Production Sites and Area Served
- 7.6.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.6.3 St.Jude Medical, Inc. Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Allergan, Plc
- 7.7.1 Allergan, Plc Drug Device Combination Products Production Sites and Area Served
- 7.7.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.7.3 Allergan, Plc Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Boston Scientific Corporation
- 7.8.1 Boston Scientific Corporation Drug Device Combination Products Production Sites and Area Served
- 7.8.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.8.3 Boston Scientific Corporation Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Novartis AG
- 7.9.1 Novartis AG Drug Device Combination Products Production Sites and Area Served
- 7.9.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.9.3 Novartis AG Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Teleflex Incorporated
- 7.10.1 Teleflex Incorporated Drug Device Combination Products Production Sites and Area Served
- 7.10.2 Drug Device Combination Products Product Introduction, Application and Specification
- 7.10.3 Teleflex Incorporated Drug Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 C.R. Bard, Inc.
- 7.12 W.L.Core & Associates, Inc.
8 Drug Device Combination Products Manufacturing Cost Analysis
- 8.1 Drug Device Combination Products Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Drug Device Combination Products
- 8.4 Drug Device Combination Products Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Drug Device Combination Products Distributors List
- 9.3 Drug Device Combination Products Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Drug Device Combination Products Market Forecast
- 11.1 Global Drug Device Combination Products Production, Revenue Forecast
- 11.1.1 Global Drug Device Combination Products Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Drug Device Combination Products Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Drug Device Combination Products Price and Trend Forecast (2019-2025)
- 11.2 Global Drug Device Combination Products Production Forecast by Regions (2019-2025)
- 11.2.1 North America Drug Device Combination Products Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Drug Device Combination Products Production, Revenue Forecast (2019-2025)
- 11.2.3 China Drug Device Combination Products Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Drug Device Combination Products Production, Revenue Forecast (2019-2025)
- 11.3 Global Drug Device Combination Products Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Drug Device Combination Products Consumption Forecast (2019-2025)
- 11.3.2 Europe Drug Device Combination Products Consumption Forecast (2019-2025)
- 11.3.3 China Drug Device Combination Products Consumption Forecast (2019-2025)
- 11.3.4 Japan Drug Device Combination Products Consumption Forecast (2019-2025)
- 11.4 Global Drug Device Combination Products Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Drug Device Combination Products Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Drug Device Combination Products. Industry analysis & Market Report on Drug Device Combination Products is a syndicated market report, published as Global Drug Device Combination Products Market Research Report 2019. It is complete Research Study and Industry Analysis of Drug Device Combination Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
